Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancerXi Chen, Hao Wang, Yun Yang et al.|Biochemical and Biophysical Research Communications|2016Cited by 18
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjectsBo Zhou, Yajun Guo, Birong Lin et al.|mAbs|2012Cited by 16
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodiesXiang Zhao, Fugui Wang, Rongrong Fu et al.|Journal of Pharmaceutical and Biomedical Analysis|2024Cited by 5
Improving product quality and productivity of an antibody-based biotherapeutic using inverted frustoconical shaking bioreactorsXuekun Wang, Huaizu Guo, Rongrong Fu et al.|Frontiers in Bioengineering and Biotechnology|2024Cited by 3
Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibodyRongrong Fu, Tao Liu, Qingcheng Guo et al.|Journal of Pharmaceutical and Biomedical Analysis|2024Cited by 0